The FDA will approve 21 drugs in 2008, up from 18 last year. However, the agency has missed its targets for 15 other products.
Washington Post
Tuesday 30 December 2008
FDA approvals up in 2008
Subscribe to:
Post Comments (Atom)
skip to main |
skip to sidebar
NEWS AND VIEWS FROM THE PHARMACEUTICAL FINE CHEMICAL AND CUSTOM MANUFACTURING SECTOR
Fine
The FINE blog keeps you up-to-date on the pharmaceutical fine chemical and custom manufacturing sector. The weekly FINE Newsletter gives senior pharmaceutical fine chemical and custom manufacturing leaders a weekly summary of the key news stories and trends for the sector. The FINE Newsletter and blog focus on coverage of companies in the pharmaceutical fine chemical custom manufacturing sector, without forgetting key news from their customers in the pharma industry.
Subscribe
To receive the newsletter, each week, please subscribe.
Advertising
|
|
|
|
||
| Read this FREE online! Full Book | PDF Summary | Podcast | ||
Blog Archive
-
▼
2008
(457)
-
▼
December
(25)
- The FDA has approved Ferring Pharmaceuticals' dega...
- Jubilant Organosys will buy back $253m foreign cur...
- FDA approvals up in 2008
- Dow-Rohm & Haas merger under threat
- Dishman breaks ground for SEZ, plans JVs
- CMC Biologics delays expansion
- Albemarle aims for $40m savings
- Dishman changes financing plans
- FDA Commissioner von Eschenbach will retire on ina...
- Good year for Ampac, sees future growth
- Cefic groups welcome API inspection programme
- ReceptoPharm will produce clinical trial materials...
- Hovione buys Pfizer plant
- BASF has opened an applications laboratory for pha...
- Actavis' Bulgarian MBO
- Chemists at the University of Bristol have develop...
- Dow cuts back
- Synthetech saw revenues rise and losses decrease i...
- Sun Pharmaceutical Industries has acquired API man...
- Pharmaterials will commence manufacture of product...
- WuXi PharmaTech will discontinue biologics manufac...
- BASF a step closer to finalising Ciba acquisition
- DSM wins NicOx deal, Archimica loses out
- Management buy-out for Seal Sands site
- Lonza does not expect its operating profit growth ...
-
▼
December
(25)
Technorati
Copyright ©2007, 2008 FINE. All rights reserved.
No comments:
Post a Comment